RxSight, Inc. (RXST) · Peers
RxSight against the 7 other companies here in its SEC industry, Ophthalmic Goods. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 8, highest first.
Measure by measure
| Measure | RXST | Peer median | Rank |
|---|---|---|---|
| Market value | $187.59M | median $2.93B | 7 of 8 |
| P/S | 1.5× | median 2.7× | 6 of 8 |
| FCF yield | -14.5% | median 2.3% | 7 of 8 |
| Gross margin | 81.1% | median 55.2% | 1 of 7 |
| Operating margin | -45.5% | median 4.1% | 7 of 8 |
| Net margin | -38.8% | median 1.1% | 7 of 8 |
| ROIC | -79.7% | median 3.7% | 7 of 8 |
| ROE | -17.8% | median 2.0% | 7 of 8 |
| Revenue growth (4y, yearly) | 56.2% | median 7.9% | 1 of 8 |
| Current ratio | 4.5× | median 2.1× | 3 of 8 |
| Stock pay / revenue | 25.9% | median 3.1% | 1 of 8 |
| Share count change | 5.1% | median 0.9% | 2 of 8 |
Green where RxSight is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| RXSTRxSight, Inc. | $187.59M | P/E – | -79.7% | 4.2 |
| ALCAlcon AG | $32.26B | P/E 32.9× | 4.3% | 5.4 |
| COOThe Cooper Companies, Inc | $11.30B | P/E 47.9× | 3.7% | 5.0 |
| BLCOBausch & Lomb Corp | $5.89B | P/E – | 2.3% | 4.2 |
| WRBYWarby Parker Inc. | $2.93B | P/E 379.1× | 1.2% | 5.1 |
| EYENational Vision Holdings, Inc. | $1.38B | P/E 27.4× | 5.9% | 4.8 |
| STAAStaar Surgical Co | $1.07B | P/E 277.8× | 5.9% | 4.1 |
| LUCYInnovative Eyewear Inc | $6.80M | P/E – | -104.2% | 5.0 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.